Global Circular mRNA Drugs Market Growth 2026-2032
The global Circular mRNA Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
In nature, circular RNA (circRNA) is ubiquitous in fungi, plants, insects, fish, and mammals, and even the genomes of some viruses are circular RNAs. Unlike linear mRNA, circular RNA is highly stable because its covalently closed ring structure protects it from exonuclease-mediated degradation. Therefore, vaccines based on circular mRNA have become a new vaccine option.
United States market for Circular mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Circular mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Circular mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Circular mRNA Drugs players cover Orna Therapeutics, Chimera Therapeutics, CirCode, Therorna, Edigene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Circular mRNA Drugs Industry Forecast? looks at past sales and reviews total world Circular mRNA Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Circular mRNA Drugs sales for 2026 through 2032. With Circular mRNA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circular mRNA Drugs industry.
This Insight Report provides a comprehensive analysis of the global Circular mRNA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Circular mRNA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Circular mRNA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circular mRNA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circular mRNA Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Circular mRNA Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Circular mRNA Drugs market?
What factors are driving Circular mRNA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Circular mRNA Drugs market opportunities vary by end market size?
How does Circular mRNA Drugs break out by Type, by Application?
In nature, circular RNA (circRNA) is ubiquitous in fungi, plants, insects, fish, and mammals, and even the genomes of some viruses are circular RNAs. Unlike linear mRNA, circular RNA is highly stable because its covalently closed ring structure protects it from exonuclease-mediated degradation. Therefore, vaccines based on circular mRNA have become a new vaccine option.
United States market for Circular mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Circular mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Circular mRNA Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Circular mRNA Drugs players cover Orna Therapeutics, Chimera Therapeutics, CirCode, Therorna, Edigene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Circular mRNA Drugs Industry Forecast? looks at past sales and reviews total world Circular mRNA Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Circular mRNA Drugs sales for 2026 through 2032. With Circular mRNA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circular mRNA Drugs industry.
This Insight Report provides a comprehensive analysis of the global Circular mRNA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Circular mRNA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Circular mRNA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circular mRNA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circular mRNA Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Circular mRNA Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Preventive Medicine
- Medicine
- Infectious Disease
- Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Orna Therapeutics
- Chimera Therapeutics
- CirCode
- Therorna
- Edigene
- Aikang Pharmaceuticals
- Curemed Bio
- Torque Bio
- Sail Biomedicines
- Orbital Therapeutics
What is the 10-year outlook for the global Circular mRNA Drugs market?
What factors are driving Circular mRNA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Circular mRNA Drugs market opportunities vary by end market size?
How does Circular mRNA Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circular mRNA Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Circular mRNA Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Circular mRNA Drugs by Country/Region, 2021, 2025 & 2032
2.2 Circular mRNA Drugs Segment by Type
2.2.1 Preventive Medicine
2.2.2 Medicine
2.2.3 Circular mRNA Drugs Sales by Type
2.2.3.1 Global Circular mRNA Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Circular mRNA Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Circular mRNA Drugs Sale Price by Type (2021-2026)
2.3 Circular mRNA Drugs Segment by Application
2.3.1 Infectious Disease
2.3.2 Cancer
2.3.3 Others
2.3.4 Circular mRNA Drugs Sales by Application
2.3.4.1 Global Circular mRNA Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Circular mRNA Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Circular mRNA Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Circular mRNA Drugs Breakdown Data by Company
3.1.1 Global Circular mRNA Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Circular mRNA Drugs Sales Market Share by Company (2021-2026)
3.2 Global Circular mRNA Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Circular mRNA Drugs Revenue by Company (2021-2026)
3.2.2 Global Circular mRNA Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Circular mRNA Drugs Sale Price by Company
3.4 Key Manufacturers Circular mRNA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Circular mRNA Drugs Product Location Distribution
3.4.2 Players Circular mRNA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CIRCULAR MRNA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Circular mRNA Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Circular mRNA Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Circular mRNA Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Circular mRNA Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Circular mRNA Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Circular mRNA Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Circular mRNA Drugs Sales Growth
4.4 APAC Circular mRNA Drugs Sales Growth
4.5 Europe Circular mRNA Drugs Sales Growth
4.6 Middle East & Africa Circular mRNA Drugs Sales Growth
5 AMERICAS
5.1 Americas Circular mRNA Drugs Sales by Country
5.1.1 Americas Circular mRNA Drugs Sales by Country (2021-2026)
5.1.2 Americas Circular mRNA Drugs Revenue by Country (2021-2026)
5.2 Americas Circular mRNA Drugs Sales by Type (2021-2026)
5.3 Americas Circular mRNA Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circular mRNA Drugs Sales by Region
6.1.1 APAC Circular mRNA Drugs Sales by Region (2021-2026)
6.1.2 APAC Circular mRNA Drugs Revenue by Region (2021-2026)
6.2 APAC Circular mRNA Drugs Sales by Type (2021-2026)
6.3 APAC Circular mRNA Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Circular mRNA Drugs by Country
7.1.1 Europe Circular mRNA Drugs Sales by Country (2021-2026)
7.1.2 Europe Circular mRNA Drugs Revenue by Country (2021-2026)
7.2 Europe Circular mRNA Drugs Sales by Type (2021-2026)
7.3 Europe Circular mRNA Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circular mRNA Drugs by Country
8.1.1 Middle East & Africa Circular mRNA Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Circular mRNA Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Circular mRNA Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Circular mRNA Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Circular mRNA Drugs
10.3 Manufacturing Process Analysis of Circular mRNA Drugs
10.4 Industry Chain Structure of Circular mRNA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Circular mRNA Drugs Distributors
11.3 Circular mRNA Drugs Customer
12 WORLD FORECAST REVIEW FOR CIRCULAR MRNA DRUGS BY GEOGRAPHIC REGION
12.1 Global Circular mRNA Drugs Market Size Forecast by Region
12.1.1 Global Circular mRNA Drugs Forecast by Region (2027-2032)
12.1.2 Global Circular mRNA Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Circular mRNA Drugs Forecast by Type (2027-2032)
12.7 Global Circular mRNA Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Orna Therapeutics
13.1.1 Orna Therapeutics Company Information
13.1.2 Orna Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
13.1.3 Orna Therapeutics Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Orna Therapeutics Main Business Overview
13.1.5 Orna Therapeutics Latest Developments
13.2 Chimera Therapeutics
13.2.1 Chimera Therapeutics Company Information
13.2.2 Chimera Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
13.2.3 Chimera Therapeutics Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chimera Therapeutics Main Business Overview
13.2.5 Chimera Therapeutics Latest Developments
13.3 CirCode
13.3.1 CirCode Company Information
13.3.2 CirCode Circular mRNA Drugs Product Portfolios and Specifications
13.3.3 CirCode Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CirCode Main Business Overview
13.3.5 CirCode Latest Developments
13.4 Therorna
13.4.1 Therorna Company Information
13.4.2 Therorna Circular mRNA Drugs Product Portfolios and Specifications
13.4.3 Therorna Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Therorna Main Business Overview
13.4.5 Therorna Latest Developments
13.5 Edigene
13.5.1 Edigene Company Information
13.5.2 Edigene Circular mRNA Drugs Product Portfolios and Specifications
13.5.3 Edigene Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Edigene Main Business Overview
13.5.5 Edigene Latest Developments
13.6 Aikang Pharmaceuticals
13.6.1 Aikang Pharmaceuticals Company Information
13.6.2 Aikang Pharmaceuticals Circular mRNA Drugs Product Portfolios and Specifications
13.6.3 Aikang Pharmaceuticals Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Aikang Pharmaceuticals Main Business Overview
13.6.5 Aikang Pharmaceuticals Latest Developments
13.7 Curemed Bio
13.7.1 Curemed Bio Company Information
13.7.2 Curemed Bio Circular mRNA Drugs Product Portfolios and Specifications
13.7.3 Curemed Bio Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Curemed Bio Main Business Overview
13.7.5 Curemed Bio Latest Developments
13.8 Torque Bio
13.8.1 Torque Bio Company Information
13.8.2 Torque Bio Circular mRNA Drugs Product Portfolios and Specifications
13.8.3 Torque Bio Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Torque Bio Main Business Overview
13.8.5 Torque Bio Latest Developments
13.9 Sail Biomedicines
13.9.1 Sail Biomedicines Company Information
13.9.2 Sail Biomedicines Circular mRNA Drugs Product Portfolios and Specifications
13.9.3 Sail Biomedicines Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sail Biomedicines Main Business Overview
13.9.5 Sail Biomedicines Latest Developments
13.10 Orbital Therapeutics
13.10.1 Orbital Therapeutics Company Information
13.10.2 Orbital Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
13.10.3 Orbital Therapeutics Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Orbital Therapeutics Main Business Overview
13.10.5 Orbital Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circular mRNA Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Circular mRNA Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Circular mRNA Drugs by Country/Region, 2021, 2025 & 2032
2.2 Circular mRNA Drugs Segment by Type
2.2.1 Preventive Medicine
2.2.2 Medicine
2.2.3 Circular mRNA Drugs Sales by Type
2.2.3.1 Global Circular mRNA Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Circular mRNA Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Circular mRNA Drugs Sale Price by Type (2021-2026)
2.3 Circular mRNA Drugs Segment by Application
2.3.1 Infectious Disease
2.3.2 Cancer
2.3.3 Others
2.3.4 Circular mRNA Drugs Sales by Application
2.3.4.1 Global Circular mRNA Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Circular mRNA Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Circular mRNA Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Circular mRNA Drugs Breakdown Data by Company
3.1.1 Global Circular mRNA Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Circular mRNA Drugs Sales Market Share by Company (2021-2026)
3.2 Global Circular mRNA Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Circular mRNA Drugs Revenue by Company (2021-2026)
3.2.2 Global Circular mRNA Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Circular mRNA Drugs Sale Price by Company
3.4 Key Manufacturers Circular mRNA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Circular mRNA Drugs Product Location Distribution
3.4.2 Players Circular mRNA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CIRCULAR MRNA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Circular mRNA Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Circular mRNA Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Circular mRNA Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Circular mRNA Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Circular mRNA Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Circular mRNA Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Circular mRNA Drugs Sales Growth
4.4 APAC Circular mRNA Drugs Sales Growth
4.5 Europe Circular mRNA Drugs Sales Growth
4.6 Middle East & Africa Circular mRNA Drugs Sales Growth
5 AMERICAS
5.1 Americas Circular mRNA Drugs Sales by Country
5.1.1 Americas Circular mRNA Drugs Sales by Country (2021-2026)
5.1.2 Americas Circular mRNA Drugs Revenue by Country (2021-2026)
5.2 Americas Circular mRNA Drugs Sales by Type (2021-2026)
5.3 Americas Circular mRNA Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circular mRNA Drugs Sales by Region
6.1.1 APAC Circular mRNA Drugs Sales by Region (2021-2026)
6.1.2 APAC Circular mRNA Drugs Revenue by Region (2021-2026)
6.2 APAC Circular mRNA Drugs Sales by Type (2021-2026)
6.3 APAC Circular mRNA Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Circular mRNA Drugs by Country
7.1.1 Europe Circular mRNA Drugs Sales by Country (2021-2026)
7.1.2 Europe Circular mRNA Drugs Revenue by Country (2021-2026)
7.2 Europe Circular mRNA Drugs Sales by Type (2021-2026)
7.3 Europe Circular mRNA Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circular mRNA Drugs by Country
8.1.1 Middle East & Africa Circular mRNA Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Circular mRNA Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Circular mRNA Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Circular mRNA Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Circular mRNA Drugs
10.3 Manufacturing Process Analysis of Circular mRNA Drugs
10.4 Industry Chain Structure of Circular mRNA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Circular mRNA Drugs Distributors
11.3 Circular mRNA Drugs Customer
12 WORLD FORECAST REVIEW FOR CIRCULAR MRNA DRUGS BY GEOGRAPHIC REGION
12.1 Global Circular mRNA Drugs Market Size Forecast by Region
12.1.1 Global Circular mRNA Drugs Forecast by Region (2027-2032)
12.1.2 Global Circular mRNA Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Circular mRNA Drugs Forecast by Type (2027-2032)
12.7 Global Circular mRNA Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Orna Therapeutics
13.1.1 Orna Therapeutics Company Information
13.1.2 Orna Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
13.1.3 Orna Therapeutics Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Orna Therapeutics Main Business Overview
13.1.5 Orna Therapeutics Latest Developments
13.2 Chimera Therapeutics
13.2.1 Chimera Therapeutics Company Information
13.2.2 Chimera Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
13.2.3 Chimera Therapeutics Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Chimera Therapeutics Main Business Overview
13.2.5 Chimera Therapeutics Latest Developments
13.3 CirCode
13.3.1 CirCode Company Information
13.3.2 CirCode Circular mRNA Drugs Product Portfolios and Specifications
13.3.3 CirCode Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CirCode Main Business Overview
13.3.5 CirCode Latest Developments
13.4 Therorna
13.4.1 Therorna Company Information
13.4.2 Therorna Circular mRNA Drugs Product Portfolios and Specifications
13.4.3 Therorna Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Therorna Main Business Overview
13.4.5 Therorna Latest Developments
13.5 Edigene
13.5.1 Edigene Company Information
13.5.2 Edigene Circular mRNA Drugs Product Portfolios and Specifications
13.5.3 Edigene Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Edigene Main Business Overview
13.5.5 Edigene Latest Developments
13.6 Aikang Pharmaceuticals
13.6.1 Aikang Pharmaceuticals Company Information
13.6.2 Aikang Pharmaceuticals Circular mRNA Drugs Product Portfolios and Specifications
13.6.3 Aikang Pharmaceuticals Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Aikang Pharmaceuticals Main Business Overview
13.6.5 Aikang Pharmaceuticals Latest Developments
13.7 Curemed Bio
13.7.1 Curemed Bio Company Information
13.7.2 Curemed Bio Circular mRNA Drugs Product Portfolios and Specifications
13.7.3 Curemed Bio Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Curemed Bio Main Business Overview
13.7.5 Curemed Bio Latest Developments
13.8 Torque Bio
13.8.1 Torque Bio Company Information
13.8.2 Torque Bio Circular mRNA Drugs Product Portfolios and Specifications
13.8.3 Torque Bio Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Torque Bio Main Business Overview
13.8.5 Torque Bio Latest Developments
13.9 Sail Biomedicines
13.9.1 Sail Biomedicines Company Information
13.9.2 Sail Biomedicines Circular mRNA Drugs Product Portfolios and Specifications
13.9.3 Sail Biomedicines Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sail Biomedicines Main Business Overview
13.9.5 Sail Biomedicines Latest Developments
13.10 Orbital Therapeutics
13.10.1 Orbital Therapeutics Company Information
13.10.2 Orbital Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
13.10.3 Orbital Therapeutics Circular mRNA Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Orbital Therapeutics Main Business Overview
13.10.5 Orbital Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Circular mRNA Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Circular mRNA Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Preventive Medicine
Table 4. Major Players of Medicine
Table 5. Global Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Circular mRNA Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Circular mRNA Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Circular mRNA Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Circular mRNA Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Circular mRNA Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Circular mRNA Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Circular mRNA Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Circular mRNA Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Circular mRNA Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Circular mRNA Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Circular mRNA Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Circular mRNA Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Circular mRNA Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Circular mRNA Drugs Producing Area Distribution and Sales Area
Table 21. Players Circular mRNA Drugs Products Offered
Table 22. Circular mRNA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Circular mRNA Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Circular mRNA Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Circular mRNA Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Circular mRNA Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Circular mRNA Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Circular mRNA Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Circular mRNA Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Circular mRNA Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Circular mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Circular mRNA Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Circular mRNA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Circular mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Circular mRNA Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Circular mRNA Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Circular mRNA Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Circular mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Circular mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Circular mRNA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Circular mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Circular mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Circular mRNA Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Circular mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Circular mRNA Drugs
Table 52. Key Market Challenges & Risks of Circular mRNA Drugs
Table 53. Key Industry Trends of Circular mRNA Drugs
Table 54. Circular mRNA Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Circular mRNA Drugs Distributors List
Table 57. Circular mRNA Drugs Customer List
Table 58. Global Circular mRNA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Circular mRNA Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Circular mRNA Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Circular mRNA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Circular mRNA Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Circular mRNA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Circular mRNA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Circular mRNA Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Circular mRNA Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Circular mRNA Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Circular mRNA Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Orna Therapeutics Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Orna Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
Table 74. Orna Therapeutics Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Orna Therapeutics Main Business
Table 76. Orna Therapeutics Latest Developments
Table 77. Chimera Therapeutics Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Chimera Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
Table 79. Chimera Therapeutics Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Chimera Therapeutics Main Business
Table 81. Chimera Therapeutics Latest Developments
Table 82. CirCode Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. CirCode Circular mRNA Drugs Product Portfolios and Specifications
Table 84. CirCode Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. CirCode Main Business
Table 86. CirCode Latest Developments
Table 87. Therorna Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Therorna Circular mRNA Drugs Product Portfolios and Specifications
Table 89. Therorna Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Therorna Main Business
Table 91. Therorna Latest Developments
Table 92. Edigene Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Edigene Circular mRNA Drugs Product Portfolios and Specifications
Table 94. Edigene Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Edigene Main Business
Table 96. Edigene Latest Developments
Table 97. Aikang Pharmaceuticals Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Aikang Pharmaceuticals Circular mRNA Drugs Product Portfolios and Specifications
Table 99. Aikang Pharmaceuticals Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Aikang Pharmaceuticals Main Business
Table 101. Aikang Pharmaceuticals Latest Developments
Table 102. Curemed Bio Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Curemed Bio Circular mRNA Drugs Product Portfolios and Specifications
Table 104. Curemed Bio Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Curemed Bio Main Business
Table 106. Curemed Bio Latest Developments
Table 107. Torque Bio Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Torque Bio Circular mRNA Drugs Product Portfolios and Specifications
Table 109. Torque Bio Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Torque Bio Main Business
Table 111. Torque Bio Latest Developments
Table 112. Sail Biomedicines Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Sail Biomedicines Circular mRNA Drugs Product Portfolios and Specifications
Table 114. Sail Biomedicines Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Sail Biomedicines Main Business
Table 116. Sail Biomedicines Latest Developments
Table 117. Orbital Therapeutics Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Orbital Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
Table 119. Orbital Therapeutics Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Orbital Therapeutics Main Business
Table 121. Orbital Therapeutics Latest Developments
Table 1. Circular mRNA Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Circular mRNA Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Preventive Medicine
Table 4. Major Players of Medicine
Table 5. Global Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Circular mRNA Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Circular mRNA Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Circular mRNA Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Circular mRNA Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Circular mRNA Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Circular mRNA Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Circular mRNA Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Circular mRNA Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Circular mRNA Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Circular mRNA Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Circular mRNA Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Circular mRNA Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Circular mRNA Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Circular mRNA Drugs Producing Area Distribution and Sales Area
Table 21. Players Circular mRNA Drugs Products Offered
Table 22. Circular mRNA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Circular mRNA Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Circular mRNA Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Circular mRNA Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Circular mRNA Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Circular mRNA Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Circular mRNA Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Circular mRNA Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Circular mRNA Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Circular mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Circular mRNA Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Circular mRNA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Circular mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Circular mRNA Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Circular mRNA Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Circular mRNA Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Circular mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Circular mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Circular mRNA Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Circular mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Circular mRNA Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Circular mRNA Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Circular mRNA Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Circular mRNA Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Circular mRNA Drugs
Table 52. Key Market Challenges & Risks of Circular mRNA Drugs
Table 53. Key Industry Trends of Circular mRNA Drugs
Table 54. Circular mRNA Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Circular mRNA Drugs Distributors List
Table 57. Circular mRNA Drugs Customer List
Table 58. Global Circular mRNA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Circular mRNA Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Circular mRNA Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Circular mRNA Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Circular mRNA Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Circular mRNA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Circular mRNA Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Circular mRNA Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Circular mRNA Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Circular mRNA Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Circular mRNA Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Circular mRNA Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Orna Therapeutics Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Orna Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
Table 74. Orna Therapeutics Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Orna Therapeutics Main Business
Table 76. Orna Therapeutics Latest Developments
Table 77. Chimera Therapeutics Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Chimera Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
Table 79. Chimera Therapeutics Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Chimera Therapeutics Main Business
Table 81. Chimera Therapeutics Latest Developments
Table 82. CirCode Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. CirCode Circular mRNA Drugs Product Portfolios and Specifications
Table 84. CirCode Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. CirCode Main Business
Table 86. CirCode Latest Developments
Table 87. Therorna Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Therorna Circular mRNA Drugs Product Portfolios and Specifications
Table 89. Therorna Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Therorna Main Business
Table 91. Therorna Latest Developments
Table 92. Edigene Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Edigene Circular mRNA Drugs Product Portfolios and Specifications
Table 94. Edigene Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Edigene Main Business
Table 96. Edigene Latest Developments
Table 97. Aikang Pharmaceuticals Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Aikang Pharmaceuticals Circular mRNA Drugs Product Portfolios and Specifications
Table 99. Aikang Pharmaceuticals Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Aikang Pharmaceuticals Main Business
Table 101. Aikang Pharmaceuticals Latest Developments
Table 102. Curemed Bio Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Curemed Bio Circular mRNA Drugs Product Portfolios and Specifications
Table 104. Curemed Bio Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Curemed Bio Main Business
Table 106. Curemed Bio Latest Developments
Table 107. Torque Bio Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Torque Bio Circular mRNA Drugs Product Portfolios and Specifications
Table 109. Torque Bio Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Torque Bio Main Business
Table 111. Torque Bio Latest Developments
Table 112. Sail Biomedicines Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Sail Biomedicines Circular mRNA Drugs Product Portfolios and Specifications
Table 114. Sail Biomedicines Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Sail Biomedicines Main Business
Table 116. Sail Biomedicines Latest Developments
Table 117. Orbital Therapeutics Basic Information, Circular mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Orbital Therapeutics Circular mRNA Drugs Product Portfolios and Specifications
Table 119. Orbital Therapeutics Circular mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Orbital Therapeutics Main Business
Table 121. Orbital Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Circular mRNA Drugs
Figure 2. Circular mRNA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Circular mRNA Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Circular mRNA Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Circular mRNA Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Circular mRNA Drugs Sales Market Share by Country/Region (2025)
Figure 10. Circular mRNA Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Preventive Medicine
Figure 12. Product Picture of Medicine
Figure 13. Global Circular mRNA Drugs Sales Market Share by Type in 2026
Figure 14. Global Circular mRNA Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Circular mRNA Drugs Consumed in Infectious Disease
Figure 16. Global Circular mRNA Drugs Market: Infectious Disease (2021-2026) & (K Units)
Figure 17. Circular mRNA Drugs Consumed in Cancer
Figure 18. Global Circular mRNA Drugs Market: Cancer (2021-2026) & (K Units)
Figure 19. Circular mRNA Drugs Consumed in Others
Figure 20. Global Circular mRNA Drugs Market: Others (2021-2026) & (K Units)
Figure 21. Global Circular mRNA Drugs Sale Market Share by Application (2025)
Figure 22. Global Circular mRNA Drugs Revenue Market Share by Application in 2026
Figure 23. Circular mRNA Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Circular mRNA Drugs Sales Market Share by Company in 2026
Figure 25. Circular mRNA Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Circular mRNA Drugs Revenue Market Share by Company in 2026
Figure 27. Global Circular mRNA Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Circular mRNA Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Circular mRNA Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Circular mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Circular mRNA Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Circular mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Circular mRNA Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Circular mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Circular mRNA Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Circular mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Circular mRNA Drugs Sales Market Share by Country in 2026
Figure 38. Americas Circular mRNA Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Circular mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Circular mRNA Drugs Sales Market Share by Region in 2026
Figure 46. APAC Circular mRNA Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Circular mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Circular mRNA Drugs Sales Market Share by Country in 2026
Figure 57. Europe Circular mRNA Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Circular mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Circular mRNA Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Circular mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Circular mRNA Drugs in 2026
Figure 74. Manufacturing Process Analysis of Circular mRNA Drugs
Figure 75. Industry Chain Structure of Circular mRNA Drugs
Figure 76. Channels of Distribution
Figure 77. Global Circular mRNA Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Circular mRNA Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Circular mRNA Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Circular mRNA Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Circular mRNA Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Circular mRNA Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Circular mRNA Drugs
Figure 2. Circular mRNA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Circular mRNA Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Circular mRNA Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Circular mRNA Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Circular mRNA Drugs Sales Market Share by Country/Region (2025)
Figure 10. Circular mRNA Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Preventive Medicine
Figure 12. Product Picture of Medicine
Figure 13. Global Circular mRNA Drugs Sales Market Share by Type in 2026
Figure 14. Global Circular mRNA Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Circular mRNA Drugs Consumed in Infectious Disease
Figure 16. Global Circular mRNA Drugs Market: Infectious Disease (2021-2026) & (K Units)
Figure 17. Circular mRNA Drugs Consumed in Cancer
Figure 18. Global Circular mRNA Drugs Market: Cancer (2021-2026) & (K Units)
Figure 19. Circular mRNA Drugs Consumed in Others
Figure 20. Global Circular mRNA Drugs Market: Others (2021-2026) & (K Units)
Figure 21. Global Circular mRNA Drugs Sale Market Share by Application (2025)
Figure 22. Global Circular mRNA Drugs Revenue Market Share by Application in 2026
Figure 23. Circular mRNA Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Circular mRNA Drugs Sales Market Share by Company in 2026
Figure 25. Circular mRNA Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Circular mRNA Drugs Revenue Market Share by Company in 2026
Figure 27. Global Circular mRNA Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Circular mRNA Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Circular mRNA Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Circular mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Circular mRNA Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Circular mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Circular mRNA Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Circular mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Circular mRNA Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Circular mRNA Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Circular mRNA Drugs Sales Market Share by Country in 2026
Figure 38. Americas Circular mRNA Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Circular mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Circular mRNA Drugs Sales Market Share by Region in 2026
Figure 46. APAC Circular mRNA Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Circular mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Circular mRNA Drugs Sales Market Share by Country in 2026
Figure 57. Europe Circular mRNA Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Circular mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Circular mRNA Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Circular mRNA Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Circular mRNA Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Circular mRNA Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Circular mRNA Drugs in 2026
Figure 74. Manufacturing Process Analysis of Circular mRNA Drugs
Figure 75. Industry Chain Structure of Circular mRNA Drugs
Figure 76. Channels of Distribution
Figure 77. Global Circular mRNA Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Circular mRNA Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Circular mRNA Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Circular mRNA Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Circular mRNA Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Circular mRNA Drugs Revenue Market Share Forecast by Application (2027-2032)
